Heritage Global Patents & Trademarks to Conduct Global Sealed-Bid Auction of Cancer Therapeutic Patent Portfolio

SAN DIEGO, July 8, 2020 /PRNewswire/ -- Affigen's Cancer Therapeutic Patent Portfolio addresses:

The Problem:  The Signature Receptor is often unique from patient-to-patient necessitating a new drug for each patient within a clinically relevant time frame.

The Solution:   The Signature Platform enables the production of patient-specific therapies against Signature Receptors with unprecedented speed and precision.

These therapies have the potential to bring a new class of safe and effective options to patients with Cancers, Autoimmune Diseases and Lymphoproliferative Disorders

View Technology Summary
View Patent Analysis Report, Patent Prosecution Analytics & Patent PDF 
View Auction Information 
View Bid Submission Form 

About Heritage Global Inc. www.hginc.com 
Heritage Global Inc. (OTCQB: HGBL, CSE: HGP) is a diversified financial services company providing acquisition, disposition, valuation and lending services for surplus and distressed assets.

About Heritage Global Patents & Trademarks
Heritage Global Patents & Trademarks is the Intellectual Property Division of Heritage Global Inc. and provides a patent monetization services via Patent Auctions and Patent Brokerage on its online monetization platform The Patent Exchange.

• Patents no longer part of strategic corporate objectives
• Patents which have never been commercialized nor developed and for which there are no plans to do so
• Unwanted patents representing ongoing renewal costs but whose market value declines with every year of non-use
• Orphan Patents acquired in mergers and acquisitions that are non-core and not needed

Contact:
Doug Berman, Managing Director
Heritage Global Patents & Trademarks
The Patent Exchange
www.patent-exchange.com 
707-245-4417
[email protected]

SOURCE Heritage Global Patents & Trademarks

Related Links

http://www.hginc.com